Gianpiero Di Leva
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
148
Citations
11,657
Est. group size
~1
Recurring co-author estimate
Active years
45
Publishing since 1981
Gianpiero Di Leva's research focuses on the role of small RNA molecules called microRNAs in cancer, particularly in breast cancer, ovarian cancer, and medulloblastoma (a type of brain tumor). His work examines how these microRNAs regulate genes involved in tumor growth, drug resistance, and tissue development, aiming to understand molecular mechanisms that could inform future cancer treatments.
Publication output was relatively low and steady through 2017-2022, then spiked sharply in 2023 (largely due to supplementary data records) before dropping back to low levels in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Lyophilized MSC-EVs attenuates COVID-19 pathogenesis by regulating the JAK/STAT pathway
Stem Cell Research & Therapy · 2025
- Tivantinib induces mitotic death in SHH medulloblastoma cell lines.
Research Square · 2024
- Supplementary Figure 3 from Alterations of the Tumor Suppressor Gene <i>ARLTS1</i> in Ovarian Cancer
2023
- Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature
Cancers · 2023
- Genetic Loss of miR-205 Causes Increased Mammary Gland Development
Non-Coding RNA · 2023
- Data from microRNA-205 Regulates HER3 in Human Breast Cancer
2023
- Supplementary Table 6 from MicroRNA Signatures in Human Ovarian Cancer
2023
- Supplementary Table 4 from MicroRNA Signatures in Human Ovarian Cancer
2023
- Supplementary Figure 1 from MicroRNA Signatures in Human Ovarian Cancer
2023
- Supplementary Table 3 from MicroRNA Signatures in Human Ovarian Cancer
2023
- Supplementary Table 1 from MicroRNA Signatures in Human Ovarian Cancer
2023
- Supplementary Figure 2 from MicroRNA Signatures in Human Ovarian Cancer
2023
- Supplementary Table 5 from MicroRNA Signatures in Human Ovarian Cancer
2023
- Data from Alterations of the Tumor Suppressor Gene <i>ARLTS1</i> in Ovarian Cancer
2023
- Supplementary Table 1 from Alterations of the Tumor Suppressor Gene <i>ARLTS1</i> in Ovarian Cancer
2023
- Figshare×10
- Cancer Cell×4
- Nature Communications×3
- Scientific Reports×3
- Cancers×2
- Carlo M. Croce
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Francesca Lovat
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jing Peng
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jia Wang
Biochemistry, Genetics and Molecular Biology · Indiana University
- Michela Garofalo
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile